Skip to main content

Table 5 GMT and GMI on Day 30 post-vaccination (PPS)

From: A post-marketing study to evaluate the safety and immunogenicity of a quadrivalent influenza split-virion vaccine in elderly people aged 60 years and older

Subtype

N

GMT (95%CI)

GMI (95%CI)

H1N1

348

303.25(267.03 ~ 344.37)

24.80(21.39 ~ 28.75)

H3N2

348

238.78(212.93 ~ 267.76)

7.26(6.38 ~ 8.25)

BV

348

73.14(64.86 ~ 82.49)

10.39(9.14 ~ 11.80)

BY

348

145.70(130.65 ~ 162.49)

7.39(6.57 ~ 8.31)

  1. Analyzed with titer detected by hemagglutination inhibition assay
  2. N: subject number of analyzing set as denominator; CI: confidence intervals;
  3. GMT: Geometric mean titer; GMI: Geometric mean increase fold at 30 days post-vaccination compared to baseline level
Back to article page

Tropical Diseases, Travel Medicine and Vaccines

ISSN: 2055-0936

Contact us